Clinical trial
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
NCT04198701 is registered in ClinicalTrials.gov with Medtronic Cardiac Ablation Solutions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 10, 2019
- Completion date
- November 28, 2022
- Enrollment
- 421 (actual)
- Sites
- 41
Conditions
As the registry lists them; a condition with its own page is linked.